Michael J. Valentino, President & CEO at Adams Respiratory Therapeutics, Inc. (ARXT), sold 15,700 shares at $37.58 ($591K) on 2007-10-01, disclosed to the SEC on 2007-10-03.
Scheduled sale ($591k) by President & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.45 | 900 | $34K | 5.7% |
| 2 | $37.49 | 200 | $7K | 1.3% |
| 3 | $37.50 | 1,500 | $56K | 9.5% |
| 4 | $37.52 | 600 | $23K | 3.8% |
| 5 | $37.54 | 200 | $8K | 1.3% |
| 6 | $37.55 | 200 |
| $8K |
| 1.3% |
| 7 | $37.56 | 1,500 | $56K | 9.5% |
| 8 | $37.57 | 900 | $34K | 5.7% |
| 9 | $37.58 | 300 | $11K | 1.9% |
| 10 | $37.61 | 700 | $26K | 4.5% |
| 11 | $37.62 | 1,200 | $45K | 7.6% |
| 12 | $37.64 | 800 | $30K | 5.1% |
| 13 | $37.67 | 200 | $8K | 1.3% |
| 14 | $37.72 | 600 | $23K | 3.8% |
| 15 | $37.73 | 100 | $4K | 0.6% |
| 16 | $37.75 | 300 | $11K | 1.9% |
| 17 | $37.76 | 100 | $4K | 0.6% |
| 18 | $37.77 | 100 | $4K | 0.6% |
| 19 | $37.78 | 2,100 | $79K | 13.4% |
| 20 | $37.79 | 600 | $23K | 3.8% |
| 21 | $37.80 | 700 | $26K | 4.5% |
| 22 | $37.81 | 100 | $4K | 0.6% |
| 23 | $37.82 | 400 | $15K | 2.6% |
| 24 | $37.83 | 200 | $8K | 1.3% |
| 25 | $37.85 | 100 | $4K | 0.6% |
| 26 | $37.86 | 200 | $8K | 1.3% |
| 27 | $37.90 | 400 | $15K | 2.6% |
| 28 | $37.92 | 300 | $11K | 1.9% |
| 29 | $37.93 | 200 | $8K | 1.3% |
| Total | $37.66 avg | 15,700 | $591K | 100% |
| Filing → |
| PLXP | BUY | 2020-11-20 | $1.0M | — | Filing → |
| PLXP | BUY | 2019-05-21 | $497K | — | Filing → |
| PLXP | BUY | 2017-06-16 | $400K | — | Filing → |